According to analyses of the Tumor Immune Estimation Resource (TIMER) database, six types of immune cells (B cells, CD8 + T cells, CD4 + T cells, macrophages, neutrophils, and dendritic cells) were associated with PROS1 expression and prognosis in patients with LGG (Fig. 12A, B). This evidence concerns the gene PROS1 and neoplasm.